Role of occult XXXX in @entity417 after partial gastrectomy.

@entity1 @entity1944 @entity417 @entity548 @entity190 @entity117 @entity3621 @entity360 @entity356 @entity68
The present investigation is a study of occult gastrointestinal @entity190 in 20 anaemic postgastrectomy @entity1 and 14 control subjects. One @entity1 in the postgastrectomy group was found to be bleeding from undetected haemorrhoids. One @entity1 in each group showed sensitivity to @entity117 with greatly increased occult @entity190 . The mean @entity190 in 18 postgastrectomy @entity1 with unexplained @entity417 was 0.6 +/- 0.5 ml/day compared with 0.5 +/- 0.5 ml/day in 13 control subjects. Only two of the 19 anaemic postgastrectomy @entity1 studied lost more than 2 ml blood/day. @entity117 @entity190 in 18 postgastrectomy @entity1 was 2.4 +/- 2.1 ml/day, compared with 2.6 +/- 2.7 ml/day in 13 controls. The pattern of @entity117 @entity190 is identical in both groups. All gastric biopsies obtained from nine @entity1 with Polya gastrectomies showed changes of @entity3621 ; some showed @entity356 and @entity1944 . Occult @entity360 is not an important factor in the pathogenesis of @entity417 after partial gastrectomy unless there is either stomal ulceration or a lesion completely unrelated to the partial gastrectomy. If @entity548 is present after partial gastrectomy a careful search for the site of bleeding is indicated. Excessive intake of @entity117 or increased sensitivity to @entity117 was not shown to be a significant factor in the pathogenesis of the @entity417 in this group of @entity1 . However, because of the inability to augment @entity68 absorption to compensate for @entity190 , it would be inadvisable for the @entity1 with a partial gastrectomy to take a high dosage of @entity117 for long periods of time, unless @entity117 -induced @entity190 is measured and shown to be very low. @entity117 administered in low dosage is not contraindicated after partial gastrectomy.
